Indication
Diarrhea secondary to inflammatory bowel disease
Diarrhea secondary to inflammatory bowel disease refers to frequent, loose, or watery stools occurring as a direct gastrointestinal complication of chronic intestinal inflammation, primarily seen in patients with ulcerative colitis or Crohn's disease. Read more about Diarrhea secondary to inflammatory bowel disease
132 drugs 63 manufacturers
Drugs that treat it
Common Diarrhea secondary to inflammatory bowel disease therapies.
IMODIUM A-D (loperamide HCl)
LOPERAMIDE (loperamide HCl)
IMODIUM ADVANCED (loperamide HCl/simethicone)
IMODIUM MULTI-SYMPTOM RELIEF (loperamide HCl/simethicone)
ANTI-DIARRHEA (loperamide HCl)
LO-PERAMIDE (loperamide HCl)
ANTI-DIARRHEAL (loperamide HCl)
ANTI-DIARRHEAL (loperamide HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiarrhea secondary to inflammatory bowel disease refers to frequent, loose, or watery stools occurring as a direct gastrointestinal complication of chronic intestinal inflammation, primarily seen in patients with ulcerative colitis or Crohn's disease.
It is characterized pathophysiologically by mucosal damage, impaired epithelial barrier function resulting in increased permeability, and defective solute and water absorption by the inflamed intestinal epithelium.
Clinically, it frequently presents as chronic or relapsing diarrhea often accompanied by abdominal cramping, fecal urgency, tenesmus, and the passage of blood or mucus, with potential downstream risks of dehydration, electrolyte imbalances, and malabsorption.
- nih.gov
Diarrhea secondary to inflammatory bowel disease refers to frequent, loose, or watery stools occurring as a direct gastrointestinal complication of chronic intestinal inflammation, primarily seen in patients with ulcerative colitis or Crohn's disease It is characterized pathophysiologically by mucosal damage, impaired epithelial barrier function resulting in increased permeability, and defective solute and water absorption by the inflamed intestinal epithelium Clinically, it frequently presents ...
- cdc.gov
Diarrhea secondary to inflammatory bowel disease refers to frequent, loose, or watery stools occurring as a direct gastrointestinal complication of chronic intestinal inflammation, primarily seen in patients with ulcerative colitis or Crohn's disease
- nih.gov
It is characterized pathophysiologically by mucosal damage, impaired epithelial barrier function resulting in increased permeability, and defective solute and water absorption by the inflamed intestinal epithelium Clinically, it frequently presents as chronic or relapsing diarrhea often accompanied by abdominal cramping, fecal urgency, tenesmus, and the passage of blood or mucus, with potential downstream risks of dehydration, electrolyte imbalances, and malabsorption
- crohnsandcolitis.ca
Clinically, it frequently presents as chronic or relapsing diarrhea often accompanied by abdominal cramping, fecal urgency, tenesmus, and the passage of blood or mucus, with potential downstream risks of dehydration, electrolyte imbalances, and malabsorption
Personalize your experience
Follow Diarrhea secondary to inflammatory bowel disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.